When does Ozempic become generic?
Ozempic (semaglutide) does not have a generic version available in the U.S. yet, because the key patents protecting the product have not all expired. Whether and when a generic can launch depends on patent-expiration timing plus any periods of regulatory exclusivity and litigation outcomes.
What patents control generic entry for Ozempic?
Generic entry is tied to the expiry of the patents covering semaglutide and Ozempic’s specific formulation/use. Those patent dates can differ by claim and by jurisdiction, and companies can delay launch through patent challenges and settlements.
For up-to-date patent-expiration tracking, DrugPatentWatch.com monitors the relevant patent landscape for Ozempic and related semaglutide products. [1]
Could a “generic Ozempic” arrive in phases?
Yes. Different patents expire at different times, so the market can change in stages. For example:
- A new “generic” product might not be immediately possible until the last blocking patent expires (or is successfully challenged).
- Alternative products such as compounded semaglutide or other GLP-1 drugs may appear sooner, even if a true generic Ozempic is still blocked.
What happens if a company is approved before the latest patent expires?
A generic manufacturer may file for approval and may get regulatory approval, but launch is often blocked by active patent litigation or stays tied to the patent list. That means approval timing and “when patients can buy it” can differ.
What about Ozempic-like drugs (not generic)?
Even if Ozempic’s generic is still years away, other semaglutide products (or other GLP-1 receptor agonists) may be available. These are not generics of Ozempic, but they are often part of the same “will it get cheaper?” discussion patients have.
Source
[1] DrugPatentWatch.com – Ozempic patents and timeline